Balchem Scholarship Supports Doctoral Student
A $110,000 gift from Balchem Corporation will expand the work of an NRI Research Assistant and enable further research in the area of choline metabolism.
NRI Welcomes New Researcher Dr. Martin Kohlmeier
Internationally-renowned researcher and author, Martin Kohlmeier, M.D., Ph.D., has relocated to Kannapolis to join the NRI team. Dr. Kohlmeier’s many accomplishments include developing consumer software about healthy foods and online nutrition education for medical students.
Dr. Steven Zeisel presents research at Harvard Nutrition Symposium
Dr. Steven Zeisel, NRI Director, spoke at the 11th Annual Postgraduate Nutrition Symposium at Harvard University. His presentation centered on the topic of choline as an essential dietary nutrient in humans.
Keimyung University Researcher Partners with NRI
Dr. Seung-Wan Ryu, Associate Professor in Department of Gastrointestinal Surgery at the Keimyung University School of Medicine in Korea, is visiting the NRI to collaborate on cutting edge nutrition research. Dr. Ryu is studying the effects of dietary choline on the growth of blood vessels in tumors.
Study Reveals Diet Rich in choline Promotes Fetal Brain Development
A mouse study by NRI scientists shows that prenatal diets that are deficient in choline—an essential nutrient that is part of all cell membranes— form fewer blood vessels in the brains of developing fetuses. These findings could prove significant for pregnant women.
NRI Scientist Joins International Public Education Campaign
Dr. Carol Cheatham, developmental cognitive neuroscientist with the NRI, is a featured expert with an international public education campaign. Sponsored by Abbott Nutrition, the makers of Similac infant formula, the campaign was designed to promote awareness of proper nutrition for pregnant women in Vietnam and Singapore.
NRI Director Heads GenoVive Scientific Advisory Board
As chair of GenoVive’s Scientific Advisory Board, Dr. Steven Zeisel, director of the NRI, will provide strategic guidance to this private corporation. GenoVive scientists develop customized meal and exercise programs that are based on individual DNA.